A Study to Evaluate the Feasibility of a Physiologic Biomarker to Assess Pain and Other Sensory Problems Using Pupillometry in Participants With Neurofibromatosis Type 1 (NF1) | MicrobiomeTrials
A Study to Evaluate the Feasibility of a Physiologic Biomarker to Assess Pain and Other Sensory Problems Using Pupillometry in Participants With Neurofibromatosis Type 1 (NF1)
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2026-02-18Est. Completion: 2027-05-01
Enrollment target: 70 participants
Locations
Children's National Medical Center, Washington D.C., District of Columbia, United States
National Institutes of Health Clinical Center, Bethesda, Maryland, United States